Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial.
Saved in:
| Title: | Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial. |
|---|---|
| Authors: | Nurmi V; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK; Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Electronic address: visa.nurmi@helsinki.fi., Mayne R; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK., Knight C; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK., Almonacid-Mendoza HL; Clinical Services, NHS Blood and Transplant, Oxford, UK., Secret S; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK; Clinical Services, NHS Blood and Transplant, Oxford, UK., Estcourt L; Clinical Services, NHS Blood and Transplant, Oxford, UK; Radcliffe Department of Medicine and BRC Haematology Theme, University of Oxford, Oxford, UK., Hepojoki J; Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Institute of Veterinary Pathology, Vetsuisse faculty, University of Zürich, Zürich, Switzerland., Šuštić T; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, the Netherlands; Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Centre for Biomolecular Research, Utrecht University, Utrecht, the Netherlands., Lamikanra AA; Clinical Services, NHS Blood and Transplant, Oxford, UK; Radcliffe Department of Medicine and BRC Haematology Theme, University of Oxford, Oxford, UK., Tsang HP; Clinical Services, NHS Blood and Transplant, Oxford, UK., Menon DK; Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, UK., Shankar-Hari M; Centre for Inflammation Research, The University of Edinburgh, Edinburgh, UK., van der Schoot CE; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, the Netherlands; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Vidarsson G; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, the Netherlands; Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences and Bijvoet Centre for Biomolecular Research, Utrecht University, Utrecht, the Netherlands., Roberts DJ; Clinical Services, NHS Blood and Transplant, Oxford, UK; Radcliffe Department of Medicine and BRC Haematology Theme, University of Oxford, Oxford, UK., Simmonds P; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK., Hedman K; Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Helsinki University Hospital Diagnostics Centre, Helsinki, Finland., Harvala H; Radcliffe Department of Medicine and BRC Haematology Theme, University of Oxford, Oxford, UK; Microbiology Services, NHS Blood and Transplant, Colindale, UK; Infection and Immunity, University College of London, London, UK. |
| Source: | The Journal of infection [J Infect] 2025 Feb; Vol. 90 (2), pp. 106412. Date of Electronic Publication: 2025 Jan 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2742 (Electronic) Linking ISSN: 01634453 NLM ISO Abbreviation: J Infect Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
